2024 |
Xencor Inc
|
Lead Independent Director |
372.9 K |
-2.9 % |
2023 |
Xencor Inc
|
Lead Independent Director |
384.2 K |
-8.1 % |
2022 |
Xencor Inc
|
Lead Independent Director |
417.9 K |
47.0 % |
2021 |
Xencor Inc
|
Lead Independent Director |
284.3 K |
-11.8 % |
2020 |
Xencor Inc
|
Lead Independent Director |
322.3 K |
-3.4 % |
2019 |
Xencor Inc
|
Lead Independent Director |
333.8 K |
22.0 % |
2018 |
Xencor Inc
|
Lead Independent Director |
273.7 K |
40.7 % |
2017 |
Xencor Inc
|
Lead Independent Director |
194.4 K |
68.3 % |
2016 |
Xencor Inc
|
Independent Director |
115.5 K |
-56.9 % |
2015 |
Xencor Inc
|
Independent Director |
268.1 K |
- |
2014 |
Xencor Inc
|
Independent Director |
- |
- |
2008 |
Gilead Sciences, Inc.
|
Senior Vice President, Head of Respiratory Therape |
- |
- |
2007 |
Gilead Sciences, Inc.
|
Senior Vice President, Head of Respiratory Therape |
- |
- |
2006 |
Gilead Sciences, Inc.
|
Senior Vice President, Head of Respiratory Therape |
- |
- |